EXTON, Pa., April 13, 2017 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, today
announced that it will release first-quarter 2017 financial results
before the market opens on Thursday, April
27, 2017, and will follow with a conference call to discuss
the results and business expectations at 9:00 a.m. Eastern Time. To participate on the
call, please dial 877-930-8295 (U.S.) or 253-336-8738
(International). The conference ID is 3829053.
A live broadcast of the conference call will be available at the
Company's website, www.westpharma.com, in the "Investors" section.
Management will refer to a slide presentation during the call,
which will be made available on the day of the call. To view the
presentation, select "Presentations" in the "Investors" section of
the Company's website.
An online archive of the broadcast will be available at the site
three hours after the live call and will be available through
Thursday, May 4, 2017, by dialing
855-859-2056 (U.S.) or 404-537-3406 (International). The conference
ID is 3829053.
About West
West Pharmaceutical Services, Inc. is a leading manufacturer of
packaging components and delivery systems for injectable drugs and
healthcare products. Working by the side of its customers from
concept to patient, West creates products that promote the
efficiency, reliability and safety of the world's pharmaceutical
drug supply. West is headquartered in Exton, Pennsylvania, and supports its
customers from locations in North and South America, Europe, Asia
and Australia. West's 2016 sales
of $1.5 billion reflect the daily use
of approximately 112 million of its components and devices, which
are designed to improve the delivery of healthcare to patients
around the world.
West and the diamond logo and By your side for a healthier
world™ are registered trademarks or trademarks of West
Pharmaceutical Services, Inc., in the
United States and other jurisdictions.
|
Investor
Contact:
|
Media
Contact:
|
|
Quintin Lai
|
Emily
Denney
|
|
Vice President,
Investor Relations
|
Vice President,
Global Communications
|
|
+1-610-594-3318
|
+1-610-594-3035
|
|
Quintin.Lai@westpharma.com
|
Emily.Denney@westpharma.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/west-to-host-first-quarter-2017-conference-call-300438851.html
SOURCE West Pharmaceutical Services, Inc.